Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1977 Jun 1;145(6):1607–1611. doi: 10.1084/jem.145.6.1607

On the occurrence of cytochrome P-450 and aryl hydrocarbon hydroxylase activity in rat brain

PMCID: PMC2180688  PMID: 194012

Abstract

The difference spectra of the carbon monoxide-complex of dithionite- reduced rat brain microsomes, compared with both reduced microsomes, alone, and the carbon monoxide-complex of oxidized microsomes, indicate the presence of small amounts of cytochrome P-450 in brain. As in liver, cytochrome P-450 in brain is degraded in vitro to its inactive form, cytochrome P-420 by methylmercury chloride. Aryl hydrocarbon hydroxylase activity is also present in rat brain microsomes and, at lower specific activity, in brain homogenates. This carcinogen metabolizing activity is increased four-fold in rats pretreated with 3- methylcholanthrene.

Full Text

The Full Text of this article is available as a PDF (385.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alvares A. P., Cohn J., Kappas A. Studies on the effects of methylmercury on ethylmorphine N-demethylase and aniline hydroxylase activities and on the conversion of cytochrome P-450 to cytochrome P-420. Drug Metab Dispos. 1974 May-Jun;2(3):259–266. [PubMed] [Google Scholar]
  2. Alvares A. P., Schilling G., Garbut A., Kuntzman R. Studies on the hydroxylation of 3,4-benzpyrene by hepatic microsomes. Effect of albumin on the rate of hydroxylation of 3,4-benzpyrene. Biochem Pharmacol. 1970 Apr;19(4):1449–1455. doi: 10.1016/0006-2952(70)90060-2. [DOI] [PubMed] [Google Scholar]
  3. Conney A. H. Pharmacological implications of microsomal enzyme induction. Pharmacol Rev. 1967 Sep;19(3):317–366. [PubMed] [Google Scholar]
  4. Inouye A., Shinagawa Y. Cytochrome b5 and related oxidative activities in mammalian brain microsomes. J Neurochem. 1965 Sep-Oct;12(9):803–813. doi: 10.1111/j.1471-4159.1965.tb10265.x. [DOI] [PubMed] [Google Scholar]
  5. Juchau M. R., Zachariah P. K., Colson J., Symms K. G., Krasner J., Yaffe S. J. Studies on human placental carbon monoxide-binding cytochromes. Drug Metab Dispos. 1974 Jan-Feb;2(1):79–86. [PubMed] [Google Scholar]
  6. Nebert D. W., Gelboin H. V. Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture. I. Assay and properties of induced enzyme. J Biol Chem. 1968 Dec 10;243(23):6242–6249. [PubMed] [Google Scholar]
  7. OMURA T., SATO R. THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. J Biol Chem. 1964 Jul;239:2370–2378. [PubMed] [Google Scholar]
  8. SUTHERLAND E. W., CORI C. F. Purification of the hyperglycemic-glycogenolytic factor from insulin and from gastric mucosa. J Biol Chem. 1949 Sep;180(2):825–837. [PubMed] [Google Scholar]
  9. Schoene B., Fleischmann R. A., Remmer H., von Oldershausen H. F. Determination of drug metabolizing enzymes in needle biopsies of human liver. Eur J Clin Pharmacol. 1972 Mar;4(2):65–73. doi: 10.1007/BF00562499. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES